Ridgepost Capital earnings were $15.3M for the trailing 12 months ending Sep 30, 2025, with 40% growth year over year. The latest RPC earnings report on Sep 30, 2025 announced Q3 2025 earnings of $2.1M, down 36.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RPC reported annual earnings of $18.7M, with -362.2% growth. The next RPC earnings date is Mar 4, 2026.
RPC past earnings growth
How has RPC's earnings growth performed historically?
What were Ridgepost Capital's earnings last quarter?
On RPC's earnings call on Invalid Date, Ridgepost Capital (NYSE: RPC) reported Q3 2025 earnings per share (EPS) of $0.02, up 100% year over year. Total RPC earnings for the quarter were $2.15 million. In the same quarter last year, Ridgepost Capital's earnings per share (EPS) was $0.01.
The next RPC earnings date is Invalid Date. Add RPC to your watchlist to be reminded of Ridgepost Capital's next earnings date.
Is Ridgepost Capital profitable or losing money?
As of the last Ridgepost Capital earnings report, Ridgepost Capital is currently profitable. Ridgepost Capital's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $15.33 million, a 24.28% increase year over year.
What was RPC's earnings growth in the past year?
As of Ridgepost Capital's earnings date in Invalid Date, Ridgepost Capital's earnings has grown 40% year over year. This is 21.63 percentage points higher than the US Asset Management industry earnings growth rate of 18.37%. RPC earnings in the past year totalled $15.33 million.
What are Ridgepost Capital's earnings expectations?
The current EPS estimate for Ridgepost Capital's earnings report in Invalid Date is $0.24.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.